Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review
- PMID: 37310064
- PMCID: PMC10286532
- DOI: 10.1177/00469580231180754
Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review
Abstract
Drug-resistant tuberculosis (DRTB) is a growing concern worldwide. The poor rate of service delivery exacerbates the severity, leading to an increase in community transmission, which is further amplified by stigma. Health care workers (HCWs) are at the forefront lines of service delivery; their efforts are suspected of resulting in stigmatization, negatively impacting patient-centered care. However, little is known about DRTB-related stigma among these HCWs, and interventions are limited. Our scoping review is significant because it provides an overview of the DRTB stigma confronting HCWs and informs subsequent stigma-reduction initiatives. Utilizing Arksey and O'Malley framework, we exhaustively searched electronic databases for relevant English-language studies published from 2010 to 2022, identifying the drivers and facilitators of DRTB-related stigma among HCWs from high-TB and -DRTB burden countries, and compiling recommendations that could reduce DRTB stigma. From 443 de-duplicated papers, 11 articles on HCWs' DRTB-related stigma were reviewed and synthesized. Fear was mentioned across included articles as a stigma driver. Other reported stigma drivers identified included feelings of discrimination, isolation, danger, lack of support, shame, and stress. Poor infection control (IC) was the leading stigma facilitator. Other stigma facilitators identified were differing IC interpretations, workforce culture, and workplace inequality facilitating to stigmatization of HCWs. Three key recommendations identified were addressing infection control issues; increase the competence of healthcare workers; and provide psychosocial assistance, emphasizing HCW safety during DRTB activities. DRTB stigma among HCWs is multifaceted, largely driven by fear and facilitated by varying implementation or interpretations of policies within the workplace. Making HCWs feel safe while conducting DRTB activities is a priority issue that should be addressed by improving IC, training and psychosocial support. More studies investigating country-specific and multilevel DRTB-related stigma among HCWs are required to inform the development of an effective stigma intervention strategy.
Keywords: DRTB stigma; TB stigma; drug-resistant tuberculosis; health workers; stigma; tuberculosis stigma.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Examining Drug-Resistant Tuberculosis Stigma Among Health Care Workers Toward the Development of a Stigma-Reduction Intervention: Protocol for a Scoping Review.JMIR Res Protoc. 2023 Jan 13;12:e43084. doi: 10.2196/43084. JMIR Res Protoc. 2023. PMID: 36637899 Free PMC article.
-
Towards a health-enabling working environment - developing and testing interventions to decrease HIV and TB stigma among healthcare workers in the Free State, South Africa: study protocol for a randomised controlled trial.Trials. 2018 Jul 4;19(1):351. doi: 10.1186/s13063-018-2713-5. Trials. 2018. PMID: 29973259 Free PMC article.
-
Waiting to inhale: factors associated with healthcare workers' fears of occupationally-acquired tuberculosis (TB).BMC Infect Dis. 2019 May 28;19(1):475. doi: 10.1186/s12879-019-4115-z. BMC Infect Dis. 2019. PMID: 31138140 Free PMC article. Clinical Trial.
-
What tuberculosis infection control measures are effective in resource-constrained primary healthcare facilities? A systematic review of the literature.Rural Remote Health. 2023 Mar;23(1):7175. doi: 10.22605/RRH7175. Epub 2023 Mar 22. Rural Remote Health. 2023. PMID: 36947945
-
Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.Presse Med. 2017 Mar;46(2 Pt 2):e53-e62. doi: 10.1016/j.lpm.2017.01.014. Epub 2017 Feb 28. Presse Med. 2017. PMID: 28256382 Free PMC article. Review.
Cited by
-
Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan - a phenomenological study.Int J Equity Health. 2025 Jul 1;24(1):185. doi: 10.1186/s12939-025-02566-4. Int J Equity Health. 2025. PMID: 40598484 Free PMC article.
-
A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis Management.J Multidiscip Healthc. 2025 Jun 17;18:3531-3544. doi: 10.2147/JMDH.S517965. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40546291 Free PMC article. Review.
References
-
- WHO. Tuberculosis. World Health Organizarion. January15, 2021. Accessed January 15, 2021. https://www.who.int/health-topics/tuberculosis
-
- WHO. Tackling the Drug-Resistant TB Crisis. WHO. Accessed January 10, 2022. https://www.who.int/activities/tackling-the-drug-resistant-tb-crisis
-
- Isaakidis P, Smith S, Majumdar S, Furin J, Reid T.Calling tuberculosis a social disease—an excuse for complacency? Lancet. 2014;384(9948):1095. - PubMed
-
- WHO. Global TB Progress at Risk. World Health Organization; 2020. Accessed November 16, 2021. https://www.who.int/news/item/14-10-2020-who-global-tb-progress-at-risk
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources